Approval · Notice of Compliance 11783 · 2010
VPRIV: Notice of Compliance 11783
Issued October 1, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11783
- Date
- October 1, 2010
- Company
- Shire Human Genetic Therapies IncLexington, Massachusetts, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VPRIV | 02357119 | Marketed |
| VPRIV | 02357100 | — |
Medicinal ingredients
- VELAGLUCERASE ALFA 400 UNIT per VIAL
- VELAGLUCERASE ALFA 200 UNIT per VIAL